Sep 30, 2014 at 17:43 | Source: Moneycontrol.com
Parabolic Drugs has informed that the 18th Annual General Meeting (AGM) of the Company was held on September 30, 2014.
Sep 30, 2014 at 16:47 | Source: Reuters
Modi, who is visiting the United States to bolster trade and investment ties, has been meeting senior Congressmen and business leaders. He met President Barack Obama at a White House dinner on Monday and the two will hold further talks on Tuesday.
Sep 30, 2014 at 14:42 | Source: Moneycontrol.com
Kilitch Drugs India Ltd has informed BSE that the 22nd Annual General Meeting (AGM) of the Company was held on September 30, 2014.
Sep 26, 2014 at 21:28 | Source: CNBC-TV18
The USFDA has served import alerts to Canadian drug company Apotex Researchs manufacturing facility in Bangalore and Indian firm Micro Labs manufacturing unit in Goa. For both the drug companies, this is their second Indian facility being banned by USFDA.
Sep 24, 2014 at 21:32 | Source: PTI
In a statement, the government said the internal guidelines issued by NPPA on May 29, 2014 and its orders on July 10 to fix prices of 108 formulation packs of anti-diabetic and cardiovascular drugs have been challenged in Bombay and Delhi High Court.
Sep 23, 2014 at 12:11 | Source: CNBC-TV18
Sanofi is a major player in the diabetes space and many of its top selling brands for like Amaryl and many other products were coming under the price control order. Hence, the company had to cut prices.
Sep 22, 2014 at 22:28 | Source: CNBC-TV18
The order was to cap prices of a list of 108 cardiovascular and diabetes drugs, not part of NLEM, and had created an uproar from the industry leading to lawsuits contesting the order. Now with the guidelines withdrawal notification, the July 2014 order, in essence, ceases to be valid.
Sep 22, 2014 at 11:09 | Source: Moneycontrol.com
Aarey Drugs & Pharmaceuticals Ltd has informed BSE that the 24th Annual General Meeting (AGM) of the Company was held on September 20, 2014 under along with Scrutinizer's Report.
Sep 19, 2014 at 13:55 | Source: PTI
The registration process will be kept open till October 30, 2014 after which that data inputting facility shall be made available to all registered users for submission of online reports in respect of form II, III and V under DPCO 2013.
Sep 19, 2014 at 12:09 | Source: Moneycontrol.com
Under the agreement, Cipla has granted Salix exclusive rights for certain patent applications in the Rifaximin Complexes patent family controlled by Cipla.